One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v126.23.4228.4228
Copy DOI Journal: Blood |  Publication Date: Dec 3, 2015 |
 Citations: 21 |
Affiliation: Massachusetts General Hospital, Fred Hutch Cancer Center, University of Michigan–Ann Arbor, Emory University, Mount Sinai Hospital, Medical College of Wisconsin, Cleveland Clinic, The Ohio State University, Horizon Oncology Center, University of Alberta, University of Calgary, Princess Margaret Cancer Centre, National and Kapodistrian University of Athens, Acetylon Pharmaceuticals (United States), Dana-Farber Cancer InstituteRicolinostat (ACY-1215), the First Selective HDAC6 Inhibitor, Combines Safely with Pomalidomide and Dexamethasone and Shows Promosing Early Results in Relapsed-and-Refractory Myeloma (ACE-MM-102 Study)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
